InBioGen Co Ltd
KRX:101140

Watchlist Manager
InBioGen Co Ltd Logo
InBioGen Co Ltd
KRX:101140
Watchlist
Price: 9 680 KRW -1.12% Market Closed
Market Cap: ₩97.2B

Balance Sheet

Balance Sheet Decomposition
InBioGen Co Ltd

Balance Sheet
InBioGen Co Ltd

Rotate your device to view
Balance Sheet
Currency: KRW
Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024
Assets
Cash & Cash Equivalents
938
1 818
676
375
186
1 021
353
186
435
0
617
8 042
9 115
23 152
9 290
6 089
5 716
Cash
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
0
Cash Equivalents
938
1 818
676
375
186
1 021
353
186
435
0
617
8 042
9 114
23 151
9 288
6 088
5 716
Short-Term Investments
213
230
0
0
0
495
0
0
0
2 309
20 210
20 000
69 920
0
0
0
0
Total Receivables
7 771
12 277
3 857
5 089
3 259
2 784
2 405
4 423
3 900
2 233
1 394
2 366
5 436
6 575
5 662
4 271
3 429
Accounts Receivables
6 441
5 149
3 665
4 916
3 166
2 733
2 352
3 101
2 391
1 483
1 380
2 201
4 854
6 246
5 494
4 182
3 285
Other Receivables
1 330
7 128
192
173
93
51
53
1 322
1 509
750
14
165
582
329
168
88
144
Inventory
2 764
707
2 296
3 921
4 610
4 945
3 680
3 903
2 880
1 066
1 728
2 129
1 014
1 482
1 532
877
111
Other Current Assets
3 030
3 231
11
831
233
523
452
5 825
5 023
7 709
8
148
363
693
250
96
24
Total Current Assets
14 716
18 263
6 839
10 216
8 287
9 767
6 890
14 337
12 238
13 318
23 957
32 685
85 847
31 902
16 733
11 332
9 280
PP&E Net
131
110
94
64
37
108
100
183
125
61
26
624
1 118
4 361
3 691
2 595
1 186
PP&E Gross
131
110
94
64
37
108
100
183
125
61
26
624
1 118
4 361
3 691
2 595
1 186
Accumulated Depreciation
314
172
162
180
213
240
273
318
358
384
419
456
186
879
1 395
2 214
2 147
Intangible Assets
82
94
71
46
23
14
7
4
2
0
0
123
536
463
511
649
191
Note Receivable
437
354
300
0
0
0
0
0
0
0
0
1 690
3 730
4 363
3 486
2 130
2 940
Long-Term Investments
0
3
3
3
0
3
3
3
3
2
29
55 064
5 000
232 141
116 798
126 236
148 404
Other Long-Term Assets
0
0
0
180
111
112
111
33
9
9
309
734
649
1 245
3 064
2 762
729
Total Assets
15 366
N/A
18 824
+23%
7 307
-61%
10 509
+44%
8 458
-20%
10 004
+18%
7 110
-29%
14 559
+105%
12 376
-15%
13 390
+8%
24 321
+82%
90 919
+274%
96 881
+7%
274 475
+183%
144 284
-47%
145 704
+1%
162 730
+12%
Liabilities
Accounts Payable
2 845
2 518
3 213
1 244
644
1 123
532
2 922
2 841
781
427
433
559
646
309
318
684
Accrued Liabilities
1
36
230
194
100
88
59
54
38
68
75
402
489
605
346
401
403
Short-Term Debt
0
0
0
817
262
742
172
0
1 389
40
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
1 151
1 247
340
1 044
0
864
0
0
9 762
4 525
62 277
33 773
264
227
Other Current Liabilities
1 256
500
1 822
854
1 199
1 011
662
460
737
429
135
13 706
12 560
14 246
1 934
1 131
802
Total Current Liabilities
4 102
3 054
5 265
4 260
3 453
3 305
2 469
3 436
5 869
1 317
636
24 303
18 133
77 775
36 362
2 114
2 117
Long-Term Debt
0
921
1 030
0
0
2 596
0
2 811
318
318
0
118
246
1 064
553
330
668
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
16 953
0
0
0
Other Liabilities
440
519
664
445
479
432
516
512
437
430
332
502
596
660
485
177
109
Total Liabilities
4 542
N/A
4 495
-1%
6 959
+55%
4 705
-32%
3 932
-16%
6 334
+61%
2 985
-53%
6 759
+126%
6 624
-2%
2 065
-69%
969
-53%
24 923
+2 472%
18 975
-24%
96 452
+408%
37 400
-61%
2 621
-93%
2 894
+10%
Equity
Common Stock
19 002
20 396
20 396
11 227
5 613
5 613
6 743
10 014
10 014
11 821
14 498
19 831
25 781
26 699
70 443
5 023
5 023
Retained Earnings
25 710
23 695
37 672
36 682
37 961
39 272
40 845
46 504
48 742
49 954
48 288
35 157
79 736
14 389
102 829
3 935
20 070
Additional Paid In Capital
17 610
17 707
17 707
31 343
36 956
37 411
38 309
44 373
44 466
49 444
58 863
83 045
133 583
138 609
140 944
135 460
135 460
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
0
48
48
450
1 069
Treasury Stock
79
79
83
83
83
83
83
83
83
83
2 385
2 385
2 385
2 385
2 385
2 448
2 448
Other Equity
0
0
0
0
0
0
0
0
97
97
663
663
663
663
663
663
663
Total Equity
10 823
N/A
14 329
+32%
348
-98%
5 805
+1 568%
4 526
-22%
3 670
-19%
4 124
+12%
7 800
+89%
5 751
-26%
11 324
+97%
23 352
+106%
65 996
+183%
77 906
+18%
178 023
+129%
106 884
-40%
143 083
+34%
159 837
+12%
Total Liabilities & Equity
15 366
N/A
18 824
+23%
7 307
-61%
10 509
+44%
8 458
-20%
10 004
+18%
7 110
-29%
14 559
+105%
12 376
-15%
13 390
+8%
24 321
+82%
90 919
+274%
96 881
+7%
274 475
+183%
144 284
-47%
145 704
+1%
162 730
+12%
Shares Outstanding
Common Shares Outstanding
8
8
8
11
11
11
13
20
20
24
28
39
51
3
7
10
10
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0
0
0
0
16
8
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett